Why the study?
Does doxycycline prevent unfavorable left ventricular remodeling in patients with acute primary anterior myocardial infarction with ST segment elevation?
RCT (n=21)
Open-label
Envelope method
No
Does doxycycline prevent unfavorable left ventricular remodeling in patients with acute primary anterior myocardial infarction with ST segment elevation?
Short-term doxycycline administration in patients with acute anterior STEMI alters matrix metalloproteinase profiles but does not prevent unfavorable left ventricular remodeling.
Answers are grounded in this paper and cite their sources.
Short-term doxycycline should not be used to prevent LV remodeling after anterior STEMI; challenges MMP inhibition as a post-MI therapeutic strategy.
Национальный исследовательский Томский государственный университет,
No takes yet. Share an insight, caveat, or question.
Керчева et al. (2018) conducted an RCT in Acute primary anterior ST-segment elevation myocardial infarction (STEMI) (n=21). Doxycycline vs. Standard therapy was evaluated on Left ventricular end-diastolic volume (EDV) at 6 months (ml) (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: